Radiocontrast-induced natriuresis associated with increased urinary urodilatin excretion

Journal of Internal Medicine

Volumn 243, Issue 2, 1998, Pages 155-162

  Haller, C ^a   Meyer, M ^c   Scheele, T ^a   Koch, A ^b   Forssmann, W G ^c   Kubler W ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b IPF PHARMACEUTICALS GMBH   (Germany)

^c Department of Internal Medicine University of Heidelberg ^*

Author keywords

Coronary angiography; Human; Natriuretic peptides; Radiocontrast

Indexed keywords

ATRIAL NATRIURETIC FACTOR; IOPAMIDOL; NONIONIC CONTRAST MEDIUM; SODIUM; URODILATIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NATRIURESIS; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0031960880     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00260.x     Document Type: Article

References (25)

1. Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature Lond 1985; 314: 264-66.
2. Zeeuw DD, Janssen WMT, Jong PED. Atrial natriuretic factor: its (patho)physiological significance in humans. Kidney Int 1992; 41: 1115-33.
3. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3: 58-65.
4. Kurnik BR, Weisberg LS, Askenase AD, Kurnik PB. Mannitol stimulates atrial natriuretic peptide release in humans. Am J Kidney Dis 1991; 17:62-8.
5. Gagelmann M, Hock D, Forssmann W-G. Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett 1988; 233: 249-54.
6. Kenny AJ, Stephenson SL. Role of endopeptidase-24.11 in the inactivation of atrial natruretic peptide. FEBS Lett 1988: 232: 1-8.
7. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann W-G. Isolation and structural analysis of "urodilatin". a new peptide of the cardiodilatin (ANP) family, extracted from human urine. Klin Wochenschr 1988; 66: 752-9.
8. Goetz KL, Drummer C, Zhu JL, Leadley R, Fiedler F, Gerzer R. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. J Amer Soc Nephrol 1990; 1: 867-74.
9. Saxenhofer H. Raselli A, Weidmann P, Forssmann W-G, Bub A. Ferrari P, et al. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol 1990: 259: F832-8.
10. Humphrey MH. Urodilatin: Renal natriuretic peptide? Amer Soc Nephrol 1991; 1: 1057-9.
11. Forssmann W-G. Urodilatin (Ularitide, INN): a renal natriuretic peptide. Nephron 1995; 69: 211-22.
12. Meyer M. Richter R, Brunkhorst R, Wrenger E, Schulz-Knappe P, Kist A. et al Urodilatin is involved in sodium homeostasis and exerts sodium-state dependent natriuretic and diuretic effects. Amer J Physiol 1996; 271: F489-97.
13. Arendt RM, Stangl E, Zähringer J, Liebisch DC, Herz A. Demonstration and characterization of alpha-human atrial natriuretic factor in human plasma. FEBS Lett 1985; 189: 57-61.
14. Forssmann W-G, Kleefeld D, Bub A, Biebl A, Raida M, Mägert HJ. et al. Urodilatin: molecular forms and specific radioimmunoassay. Acta Endocrinologica (Copenhagen) 1992; 126: 165 (abstract).
15. Drummer C, Fiedler F, Bub A, Kleefeld D, Dimitriades E. Gerzer R. et al. Development and application of a urodilatin (CDD/ANP-95-126) specific radioimmunoassay. Pflüger's Arch 1993; 423: 372-7.
16. Drummer C, Gerzer R, Heer M, Molz B, Bie P, Schlossberger M. et al. Effects of an acute saline infusion on fluid and electrolyte metabolism in humans. Am J Physiol 1992; 262: F744-54.
17. Heer M, Drummer C, Baisch F, Gerzer R. Long term elevations of dietary sodium produce parallel increases in the renal excretion of urodilatin and sodium. Pflügers Arch 1993; 425: 390-4.
18. Rudnik MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995;47:254-61.
19. Brezis M, Rosen S, Hypoxia of the renal medulla - its implications for disease. New Engl J Med 1995: 332: 647-55.
20. Bentley MD, Fiksen-Olsen MJ. Romero JC. Effect of atriopeptin II on contrast medium-induced changes in renal blood flow. Kidney Int 1989; 36: 13-9.
21. Weisberg LS, Kurnik PB. Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259-65.
22. Fang LS, Sirota RA, Ebert TH, Lichtenstein NS. Low fractional excretion of sodium with contrast-media induced acute renal failure. Arch Int Med 1980; 1440: 531-3.
23. Cedidi C, Meyer M, Kuse ER. Schulz-Knappe P, Ringe B, Frei U, et al. Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur J Clin Invest 1994; 24: 632-9. Issn: 0014-2972.
24. Hummel M. Kuhn M. Bub A. Mann B. Schneider B. von Eickstedt KW. et al. Urodilatin. a new therapy to prevent kidney failure after heart transplantation. J Heart Transplantation 1992; 12: 209-18.
25. Wiebe K. Meyer M. Wahlers T. Zenker D, Schulze F-P. Michels P. et al. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide). Eur J Med Res 1996: 1: 259-65.